This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...
The new company combines Tahoe’s AI-powered target discovery engine with Alloy’s industry-leading ADC development ...
Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today presented key strategic priorities and ...
Vertical integration for CDMOs in manufacturing ADCs offers an opportunity to reduce costs and create a more resilient supply ...
The integration of flexible manufacturing, process intensification, and sustainability is redefining the global supply chain.
Goldman Sachs and Quadria Capital-backed Aragen Life Sciences is expanding India’s role in its global operations as demand ...
Rakuten Medical, Inc. and LOTTE Biologics today announced that they have signed a biopharmaceutical contract manufacturing ...
Unchained Labs, the life sciences company that's all about getting biologics and gene therapy researchers the right tool for the job, just launched a brand-new application on Stunner today that ...
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has ent ...
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company,' 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results